Home > Insider Trading > Filing (0000059478-19-000246)

Filing Details

Accession Number:: 0000059478-19-000246
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-09-09 11:59:07
Reporting Period:: 2019-09-03

Accepted Time:: 2019-09-09 11:59:07
Original Submission Date:: 2019-09-04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1596336	G Alfonso Zulueta	Lilly Corporate Center Indianapolis IN 46285	Svp & President, Lilly Int'l	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-09-03	11,192	$112.88	46,614	No	4	S	Direct
Common Stock	Disposition	2019-09-03	3,808	$113.69	42,806	No	4	S	Direct
Common Stock	Disposition	2019-09-03	4,500	$112.54	38,306	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 31, 2019.
This transaction is being amended to correct the price range reported on the Form 4 filed on 09/04/19. This transaction was executed in multiple trades at prices ranging from $112.50 to $113.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction is being amended to correct the price range reported on the Form 4 filed on 09/04/19. This transaction was executed in multiple trades at prices ranging from $113.50 to $113.85. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction is being amended to correct the total number of shares and price previously reported as part of multiple trades on the Form 4 filed on 09/04/19. This transaction was executed in one trade at a price of $112.54. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.